Allarity Therapeutics, Inc. Common Stock (ALLR) is a publicly traded Healthcare sector company. As of May 21, 2026, ALLR trades at $1.52 with a market cap of $22.11M and a P/E ratio of -2.04. ALLR moved -2.35% today. Year to date, ALLR is +33.04%; over the trailing twelve months it is +35.45%. Its 52-week range spans $0.61 to $2.35. Analyst consensus is buy with an average price target of $9.75. Rallies surfaces ALLR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ALLR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ALLR recently traded at $1.52. Market cap is $22.11M. P/E ratio is -2.04. Revenue is $345.00K.
| Metric | Value |
|---|---|
| Price | $1.52 |
| Market Cap | $22.11M |
| P/E Ratio | -2.04 |
| EPS | $-0.72 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.35 |
| 52-Week Low | $0.61 |
| Volume | 1.50K |
| Avg Volume | 0 |
| Revenue (TTM) | $345.00K |
| Net Income | $-11.25M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $320.00K | $-11.23M | $-0.78 |
| 2024 | $0 | $-24.52M | $-15.65 |
| 2023 | $0 | $-11.90M | $-10.26 |
| 2022 | $0 | $-16.06M | $-2.21 |
1 analysts cover ALLR: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.75.